Atea Pharmaceuticals, Inc.
AVIR
$3.08
$0.0150.49%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -168.39M | -174.01M | -176.00M | -163.66M | -135.96M |
| Total Depreciation and Amortization | 416.00K | 416.00K | 416.00K | 416.00K | 416.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.95M | 36.17M | 34.67M | 33.63M | 33.98M |
| Change in Net Operating Assets | -7.48M | 10.48M | 19.42M | 34.20M | 16.16M |
| Cash from Operations | -135.50M | -126.94M | -121.49M | -95.41M | -85.40M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.11M | 87.25M | 150.75M | 72.63M | 40.30M |
| Cash from Investing | 56.11M | 87.25M | 150.75M | 72.63M | 40.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 267.00K | 267.00K | 242.00K | 242.00K | 257.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 267.00K | 267.00K | 242.00K | 242.00K | 257.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.13M | -39.42M | 29.50M | -22.54M | -44.84M |
